Count | |
| 9 | |
| 9 | |
| 5 | |
| 3 | |
Dopamine Agents/administration & dosage/blood/*therapeutic use | 1 |
| 1 | |
| 2 | |
| 2 | |
| 9 | |
| 1 | |
| 9 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Dopamine Agents/antagonists & inhibitors/chemistry/*metabolism | 1 |
Dopamine Agents/adverse effects/pharmacokinetics/*pharmacology | 1 |
| 5 | |
| 2 | |
| 12 | |
| 29 | |
| 1 | |
| 4 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
Dopamine/analogs & derivatives/*pharmacology/therapeutic use | 1 |
| 3 | |
| 1 | |
Dopamine Agonists/administration & dosage/pharmacology/*therapeutic use | 1 |
Dopamine Agonists/adverse effects/*pharmacokinetics/therapeutic use | 1 |
| 5 | |
| 43 | |
| 10 | |
| 57 | |
| 33 | |
| 6 | |
| 1 | |
| 24 | |
| 19 | |
| 10 | |
| 7 | |
| 1 | |
| 18 | |
| 29 | |
| 19 | |
| 9 | |
| 29 | |
| 11 | |
| 15 | |
| 29 | |
| 104 | |
| 228 | |
| 2 | |
| 131 | |
| 52 | |
| 13 | |
| 57 | |
| 398 | |
| 6 | |
| 15 | |
| 24 | |
| 121 | |
| 32 | |
| 4 | |
| 2 | |
| 9 | |
| 24 | |
| 30 | |
| 1 | |
| 4 | |
| 7 | |
| 29 | |
| 13 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 2 | |
| 2 | |
| 2 | |